Unveiling Pancreatic Cancer Insights with Patient-Derived Xenografts | Metabolic and Molecular Changes in Tumor Models

In this episode of SciBud, we dive into groundbreaking research on pancreatic ductal adenocarcinoma (PDAC) and how patient-derived xenograft models (PDX) are shedding light on this aggressive cancer. Join your host, Maple, as we explore a significant study that establishes 33 PDX models from 43 PDAC patients, using advanced techniques like NMR spectroscopy and RNA sequencing to analyze metabolic and molecular changes over time. Discover how these models closely mimic the original tumors while also evolving, which could influence drug testing and therapeutic strategies. Although promising, the research also highlights the complexities and limitations of translating findings from mouse models to human treatments. Tune in to learn about the exciting implications for precision medicine and the importance of maintaining a critical perspective as we navigate the evolving landscape of cancer research. Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/67